0.0003
0.0000
(0.00%)
At close: January 31 at 3:00:00 PM EST
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Operating Cash Flow
-369.2290
-624.6360
-903.4890
-682.3330
-93.1900
Investing Cash Flow
--
--
--
--
0.0050
Financing Cash Flow
357.0500
581.8000
787.0720
862.8230
85.3990
End Cash Position
9.8120
21.4150
64.2510
180.6680
0.1780
Income Tax Paid Supplemental Data
-0.8000
--
--
--
--
Interest Paid Supplemental Data
80.2170
97.9280
107.5740
4.5020
6.9550
Issuance of Debt
443.0500
702.0500
1,412.5000
537.5000
24.2870
Repayment of Debt
-86.0000
-165.2500
-650.6280
-49.2870
-7.2000
Repurchase of Capital Stock
--
-5.0000
-150.0000
--
--
Free Cash Flow
-369.2290
-624.6360
-903.4890
-682.3330
-93.1900
9/30/2020 - 9/21/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1BT.F Enlivex Therapeutics Ltd.
1.0500
0.00%
GYX.F Futura Medical plc
0.1750
-50.00%
HQ1.MU Oruka Therapeutics Inc. R
12.00
+5.26%
PI3.DU Gubra AS
88.40
-0.23%
F6T.MU Fate Therapeutics Inc
1.2810
0.00%
CVAC.VI CureVac N.V.
3.6780
-2.13%
ASCLF Ascletis Pharma Inc.
0.2393
0.00%
471A.F aTyr Pharma, Inc.
3.5800
+3.47%
1AEA.F argenx SE
635.00
+2.42%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4690
+1.52%